e-learning
resources
Virtual 2020
Pre-Congress Content
Multidrug-resistant tuberculosis
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Results of drug susceptibility testing of Mycobacterium tuberculosis isolated from sputum and surgical material from pulmonary tuberculosis patients
D. Vakhrusheva (Ekaterinburg (Sverdlovsk Oblast), Russian Federation), K. Belousova (Ekaterinburg (Sverdlovsk Oblast), Russian Federation), T. Umpeleva (Ekaterinburg (Sverdlovsk Oblast), Russian Federation), N. Eremeeva (Ekaterinburg (Sverdlovsk Oblast), Russian Federation)
Source:
Virtual Congress 2020 – Multidrug-resistant tuberculosis
Session:
Multidrug-resistant tuberculosis
Session type:
E-poster session
Number:
471
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
D. Vakhrusheva (Ekaterinburg (Sverdlovsk Oblast), Russian Federation), K. Belousova (Ekaterinburg (Sverdlovsk Oblast), Russian Federation), T. Umpeleva (Ekaterinburg (Sverdlovsk Oblast), Russian Federation), N. Eremeeva (Ekaterinburg (Sverdlovsk Oblast), Russian Federation). Results of drug susceptibility testing of Mycobacterium tuberculosis isolated from sputum and surgical material from pulmonary tuberculosis patients. 471
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Related content which might interest you:
Mycobacterium tuberculosis DNA detection in urine samples from pulmonary tuberculosis patients
Source: Annual Congress 2008 - Genetics, immunology and microbiology of tuberculosis
Year: 2008
Pulmonary tuberculosis with primary drug resistant mycobacterium tuberculosis -treatment outcomes
Source: Eur Respir J 2004; 24: Suppl. 48, 657s
Year: 2004
Role of 2-month sputum smears in predicting culture conversion in pulmonary tuberculosis
Source: Eur Respir J 2011; 37: 376
Year: 2011
Pulmonary tuberculosis among elderly and senile-aged patients depending on Mycobacterium strains
Source: International Congress 2017 – TB: co-morbidities and outcome
Year: 2017
Risk factors for Mycobacterium tuberculosis infection among contacts of pulmonary tuberculosis patients
Source: Annual Congress 2012 - Tuberculous and non-tuberculous mycobacterial infections: epidemiology I
Year: 2012
Susceptibility of
Mycobacterium tuberculosis
strains to fluoquinolones, obtained from chronic patients with multidrug resistant pulmonary tuberculosis
Source: Eur Respir J 2001; 18: Suppl. 33, 315s
Year: 2001
Exposure to mycobacterium tuberculosis during bronchoscopy in patients with unexpected pulmonary tuberculosis
Source: International Congress 2016 – Epidemiological insights into tuberculosis pathogenesis
Year: 2016
Comparative analysis of detection of Mycobacterium tuberculosis and rifampin resistance determination through microbiological and molecular genetics methods for pulmonary tuberculosis patients with presence or absence of sputum
Source: Annual Congress 2012 - Microbiological advances in the diagnosis of tuberculosis
Year: 2012
Detection of isoniazid or rifampin resistant
Mycobacterium tuberculosis
in patients with cavity and previously treated for tuberculosis - usefulness of rapid drug susceptibility test with sputum samples by reverse hybridization assay
Source: Annual Congress 2005 - Resistant and multidrug resistant tuberculosis
Year: 2005
Mycobacterial non-tuberculosis infection in patients operated on for pulmonary tuberculosis
Source: Virtual Congress 2020 – Thoracic surgery: lung cancer and infectious disease
Year: 2020
Response to
M. tuberculosis
selected RD1 peptides in Ugandan HIV-infected patients with smear positive pulmonary tuberculosis
Source: Annual Congress 2008 - Interferon-gamma release assay tests for diagnosing tuberculosis infection and disease
Year: 2008
Development of
mycobacterium tuberculosis
additional drug resistance during chemotherapy of disseminated pulmonary tuberculosis
Source: Eur Respir J 2007; 30: Suppl. 51, 663s
Year: 2007
Method of treatment of destructive tuberculosis of single lung with extensively drug resistant mycobacteria tuberculosis
Source: Annual Congress 2011 - Extrapulmonary tuberculosis and surgical interventions
Year: 2011
Pneumonectomy in lung infections with
Mycobacterium tuberculosis
Source: Eur Respir J 2001; 18: Suppl. 33, 459s
Year: 2001
Lung function evolution in patients with microbiological isolation of Mycobacterium abscessus
Source: International Congress 2019 – Clinical and translational studies of bronchiectasis and non-TB mycobacterial infection
Year: 2019
Frequency of endobronchial tuberculosis in patients with active pulmonary tuberculosis is high
Source: Eur Respir J 2004; 24: Suppl. 48, 33s
Year: 2004
Impact of T-SPOT.
TB
test to exclude active
Mycobacterium tuberculosis
complex infection in patients with mycobacterial disease
Source: Eur Respir J 2006; 28: Suppl. 50, 139s
Year: 2006
Hair-analysis for acetyl-isoniazid/isoniazid ratio and N-acetyl-transferase-2-genotype in patients on treatment for mycobacterium tuberculosis infection
Source: Annual Congress 2011 - Tuberculosis: from bench to bedside
Year: 2011
Comparison of the tuberculin skin test and two commercial blood tests for diagnosing active
mycobacterium tuberculosis
infection and nontuberculous mycobacterium infection
Source: Annual Congress 2007 - Gamma-interferon-based tests to diagnose tuberculosis infection and disease
Year: 2007
Drug resistance of
Mycobacterium tuberculosis
isolated from tuberculosis inflammatory foci
Source: Eur Respir J 2005; 26: Suppl. 49, 654s
Year: 2005
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept